The Journal of Pediatrics
Volume 156, Issue 4 , Page 689 , April 2010

Muscular dystrophy revealed by incidentally discovered elevated aminotransferase levels

References 

  1. Ciafaloni E, Fox DJ, Pandya S, Westfield CP, Puzhankara S, Romitti PA, et al. Delayed diagnosis in Duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). J Pediatr. 2009;155:380–385
  2. Kaufmann P. Missed opportunities for Duchenne muscular dystrophy. J Pediatr. 2009;155:309–310
  3. Fontanella A, Vajro P, Gasparo Rippa P, Vegnente A, La Manna A, Santoro L, et al. Unsuspected myopathy in children with persistent hypertransaminasemia erroneously attributed to liver disease. Ital J Gastroenterol. 1989;21:229–231
  4. Robinson A. Rationale for cost-effective laboratory medicine. Clin Microbiol Rev. 1994;7:185–199
  5. Schwartz KB, Burris GC, De Mello DE, Hyams JS, Biller JA, Maksimak MG, et al. Prolonged elevation of transaminase concentration in children with unsuspected myopathy. Am J Dis Child. 1984;138:1121–1124
  6. Urganci N, Arapoglu M, Serdaroglu P, Nuholu A. Incidental raised transaminases: a clue to muscle disease. Ann Tropical Pediatr. 2006;26:345–348
  7. Vajro P, Di Cosmo N, Capuano G. Approach to the asymptomatic child with protracted hypertransaminasemia. In:  Guandalini S editors. Essential pediatric gastroenterology, hepatology, and nutrition. New York: McGraw-Hill; 2005;p. 335–344
  8. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology. 2002;123:1367–1384

PII: S0022-3476(09)01156-1

doi: 10.1016/j.jpeds.2009.11.047

The Journal of Pediatrics
Volume 156, Issue 4 , Page 689 , April 2010

Article Tools